Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 24, 2005. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details a specific transaction where Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust ("the GSK Trust"), transferred 2,991 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction was advised to the Company on October 24, 2005.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust where all employees or former employees are potential beneficiaries. Three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the shares held by the GSK Trust in the same capacity as other employees.
Key Facts for Investor Verification
- The filing reports a transfer of 2,991 Ordinary Shares from the GSK Trust to employee plan participants.
- The transaction date and notification date are both October 24, 2005.
- Three specific directors have an interest in the GSK Trust shares as potential beneficiaries.
- This document does not contain financial results or operational updates for the company.